Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00284986
What this trial is testing

Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants

Who this might be right for
Graft Versus Host Disease
Mesoblast, Inc. 11
Not applicableStudy completedNCT03093805
What this trial is testing

Topical Vitamin D in Acute Graft Versus Host Disease of the Skin

Who this might be right for
Graft Vs Host Disease
Children's Hospital Medical Center, Cincinnati 10
Early research (Phase 1)Study completedNCT01318330
What this trial is testing

Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)

Who this might be right for
Graft-vs-Host Disease
HomeoTherapy Co., Ltd 10
Testing effectiveness (Phase 2)Looking for participantsNCT06626737
What this trial is testing

Dapagliflozin in Allo-HCT for aGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
The First Affiliated Hospital of Soochow University 72
Early research (Phase 1)Study completedNCT03327857
What this trial is testing

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

Who this might be right for
Steroid-refractory Acute Graft-versus-Host DiseaseTreatment-refractory Acute Graft-versus-Host Disease
AltruBio Inc. 37
Not applicableUnknownNCT02254798
What this trial is testing

Biomarkers for Acute Graft-versus-host Disease

Who this might be right for
Acute GVH Disease
Assistance Publique - Hôpitaux de Paris 315
Large-scale testing (Phase 3)Study completedNCT01113255
What this trial is testing

Validation of a Simulated Clinical Evaluation of Ventilators

Who this might be right for
Respiratory DiseasesChronic and Acute Respiratory Failure
Assistance Publique - Hôpitaux de Paris 54
Large-scale testing (Phase 3)Study completedNCT00004255
What this trial is testing

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Chimeric Therapies
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT05090384
What this trial is testing

Pediatric GVHD Low Risk Steroid Taper Trial

Who this might be right for
Acute Graft vs Host DiseaseAllogeneic Bone Marrow TransplantationAdverse Effects
John Levine 50
Large-scale testing (Phase 3)Study completedNCT02461121
What this trial is testing

HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk

Who this might be right for
Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 156
Large-scale testing (Phase 3)Study completedNCT04167514
What this trial is testing

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Who this might be right for
Graft Versus Host Disease (GVHD)
CSL Behring 136
Testing effectiveness (Phase 2)Study completedNCT00823316
What this trial is testing

Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Leukemia
Medipost Co Ltd. 10
Large-scale testing (Phase 3)Ended earlyNCT01749111
What this trial is testing

Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoid LeukemiaMyeloproliferative Disease+3 more
Hospital Israelita Albert Einstein 3
Testing effectiveness (Phase 2)Looking for participantsNCT07509749
What this trial is testing

Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)

Who this might be right for
GVHD, AcuteStem Cell Transplant Complications
Daihong Liu 54
Large-scale testing (Phase 3)WithdrawnNCT00006451
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT02743351
What this trial is testing

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+3 more
Fate Therapeutics 96
Testing effectiveness (Phase 2)Looking for participantsNCT06815003
What this trial is testing

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+3 more
City of Hope Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT02683525
What this trial is testing

Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Sherif S. Farag 37
Not applicableStudy completedNCT00088543
What this trial is testing

Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant

Who this might be right for
Acute Myelogenous Leukemia (AML)Acute Lymphocytic Leukemia (ALL)Graft vs. Host Disease (GvHD)
Genzyme, a Sanofi Company 60
Next Page